Chronic Venous Disease and the Leukocyte-Endothelium Interaction: From Symptoms to Ulceration

Abstract

The mechanisms regulating varicose vein development and the subsequent skin sequelae seen in chronic venous disease (CVD) have been investigated recently. Despite the diversity of signs and symptoms associated with the disease, it seems likely that they are related to venous hypertension. Valvular incompetence is the most important cause of venous hypertension. Recent findings suggest that inflammatory processes are involved in the structural remodeling in venous valves and in the vein wall, leading to valvular incompetence and the development of varicose veins. This has been shown by Ono and colleagues, who found infiltration of valve leaflets and the venous wall by leukocytes (monocytes and tissue macrophages) in all valve specimens from patients with CVD and in none from controls. Further work by Takase and colleagues confirmed this hypothesis. Vein wall remodeling is likely to involve the complex interplay of a range of factors, including an altered ratio between metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), and elevated levels of cytokines and growth factors favor an alteration of the extracellular matrix. Neutrophils and mast cells and their interaction with the venous endothelium are believed to play an important role in the initiation of the inflammatory response in CVD. The transmission of high venous pressures to the dermal microcirculation results in the stimulation of an inflammatory process in which cytokine and growth factor release leads to leukocyte migration into the interstitium and the initiation of further inflammatory events. This process is associated with the intense dermal fibrosis and tissue remodeling seen in chronic venous insufficiency. The many manifestations of the disease are frequently associated with symptoms usually ascribed to CVD. The proportion of patients with symptoms increases with increasing CEAP clinical classes, but the mechanisms underlying symptom appearance have not been elucidated. It has been postulated that it is related to the inflammatory cascade of events seen at all stages of CVD and in which the leukocyte and its interaction with the endothelium play a key role. It is increasingly believed that the emerging twin themes of disturbed venous flow patterns and chronic inflammation underlie and link all the manifestations of the disease. Among the many pathophysiologic mechanisms at work, the leukocyte-endothelium interactions seem to be important in many aspects of the disease and have been identified as a possible target for pharmacologic intervention. Pharmacologic agents that could attenuate various elements of the inflammatory cascade and inhibit the inflammatory process might offer a greater opportunity to prevent future morbidity. It seems reasonable to speculate that such treatment could reduce the risk of CVD progression if applied as soon as the first symptoms appear.

Get full access to this article

View all access options for this article.

References

Ramelet AA, Kern P, Perrin M, eds: Les varices et télangiectasies (in French). Paris: Masson, 2003, pp 7-16.

Porter JM

Moneta GL

: International Consensus Committee on chronic venous disease. Reporting standards in venous disease: An update. J Vasc Surg 21:635-645, 1995.

Pannier-Fischer F

Rabe E

: Epidemiology of chronic venous diseases. Hautarzt 54:1037-1044, 2003.

Jawien A

Grzela T

Ochwat A

: Prevalence of chronic venous insufficiency in men and women in Poland: Multicentre cross-sectional study in 40,095 patients. Phlebology 18:110-122, 2003.

Labropoulos N

: Hemodynamic changes according to the CEAP classification. Phlebolymphology 40:130-136, 2003.

Masuda EM

Kisner RL

Eklof B

et al

: Practical application of the CEAP classification. In: Chronic Venous Insufficiency, Diagnosis and Treatment, ed. by

Ballard JL

Bergan JJ.

London: Springer-Verlag London Limited, 2000, pp 41-49.

Scuderi A

Raskin B

Assal FA

et al

: The incidence of venous disease in Brazil based on the CEAP classification. An epidemiological study. Int Angiol 21:316-321, 2002.

Carpentier PH

Cornu-Thénard A

Uhl JF

et al

, and the

European working group on the clinical characterisation of venous disorders: Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders

: A multicenter evaluation of 872 patients. J Vasc Surg 37:827-833, 2003.

Boisseau MR

: Pharmacologie des médicaments veinotoniques: Données actuelles sur leur mode d’action et les cibles thérapeutiques (in French). Angéiologie 52:71-77, 2000.

10.

Boisseau M

Freyburger G

Busquet M

et al

: Hemorheological disturbances in venous insufficiency after induced stasis. Clin Hemorheol 9:161-163, 1989.

11.

Le Devehat C

Boisseau MR

Vimeux M

et al

: Hemorheological factors in the pathophysiology of venous disease. Clin Hemorheol 9:861-870, 1989.

12.

Kahn SR

M’lan CE

Lamping DL

et al

; VEINES Study Group: Relationship between clinical classification of chronic venous disease and patient-reported quality of life: Results from an international cohort study. J Vasc Surg 39:823-828, 2004.

13.

Labropoulos N

: Inflammation parallels severity of chronic venous insufficiency. Phlebology 18:78-82, 2003.

14.

Bradbury A

Evans C

Allan P

et al

: What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 318:353-356, 1999.

15.

Bradbury A

Evans CJ

Allan P

et al

: The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: The Edinburgh Vein Study. J Vasc Surg 32:921-931, 2000.

16.

Howlader MH

Coleridge Smith PD

: Symptoms of chronic venous disease and association with systemic inflammatory markers. J Vasc Surg 38:950-954, 2003.

17.

Agence Nationale d’Accréditation et d’Evaluation de la Santé (in French). Evaluation et suivi de la douleur chronique chez l’adulte en médecine ambulatoire (in French). Available at: www.anaes.fr

18.

Perrin M

Arnould B

Regnault A

et al

: Relationship between symptoms, signs, reflux and quality of life in patients with chronic venous disease: A multicenter study. Oral presentation at the 16th Annual Meeting of the American Venous Forum (AVF), Orlando, USA, February 26-29, 2004.

19.

Ramelet AA

: Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology 52(suppl):S49-S56, 2001.

20.

Garde C

Nicolaides A

Guex JJ

et al

: First consensus meeting on venoactive drugs. Effects of venoactive agents on edema in chronic venous disease. Phlébologie - Annales Vasculaires 57:7-13, 2004.

21.

Levick JR

McHale N

: The physiology of lymph production and propulsion. In: Diseases of the Lymphatics, ed. by

Browse N

Burnand KG

Mortimer PS.

London: Arnold, 2003, pp 44-64.

22.

McCloskey KD

Toland HM

Hollywood MA

et al

: Hyperpolarisation-activated inward current in isolated sheep mesenteric lymphatic smooth muscle. J Physiol 521:201-211, 1999.

23.

Hagendoorn J

Padera TP

Kashiwagi S

et al

: Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 95:204-209, 2004.

24.

International Task Force

: The management of chronic venous disorders of the leg: An evidence-based report of an international task force. Phlebology 14(suppl 1):23-34, 1999.

25.

Schultz-Ehrenburg U

Reich S

Robak-Pawelczyk B

et al

: Prospective epidemiological study of developing varicose veins over a period of two decades (Bochum I-IV). Abstract presented at the 2003 UIP World Chapter Meeting. August 27-31, 2003, in San Diego, CA, USA.

26.

Aravind B

Davies AH

: Editorial. Phlebology 19:55-56, 2004.

27.

Ono T

Bergan JJ

Schmid-Schönbein GW

et al

: Monocyte infiltration into venous valves. J Vasc Surg 27:158-166, 1998.

28.

Coleridge Smith PD

Bergan JJ

: Inflammation in venous disease. In: Molecular Basis for Microcirculatory Disorders, ed. by

Schmid-Schönbein GW

Granger N.

Paris: Springer-Verlag, 2003, pp 489-500.

29.

Yamada T

Tomita S

Mori M

et al

: Increased mast cell infiltration in varicose veins of the lower limbs: A possible role in the development of varices. Surgery 119:494-497, 1996.

30.

Jacob MP

Badier-Commander C

Fontaine V

et al

: Extracellular matrix remodeling in the vascular wall. Pathol Biol 49:326-332, 2001.

31.

Badier-Commander C

Verbeuren T

Lebard C

et al

: Increased TIMP/MMP ratio in varicose veins: A possible explanation for extracellular matrix accumulation. J Pathol 192:105-112, 2000.

32.

Badier-Commander C

Couvelard A

Henin D

et al

: Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 193:398-407, 2001.

33.

Thomas PR

Nash GB

Dormandy JA

: White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. BMJ 296:1693-1695, 1988.

34.

Vanscheidt WQ

Kresse O

Hach-Wunderle V

et al

: Leg ulcer patients: No decreased fibrinolytic response but white cell trapping after venous occlusion of the upper limb. Phlebology 7:92-96, 1992.

35.

Takase S

Schmid-Schönbein G

Bergan JJ

: Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30:148-156, 1999.

36.

Pappas PJ

You R

Rameshwar P

et al

: Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor b1 gene expression and protein production. J Vasc Surg 30:1129-1145, 1999.